BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7935855)

  • 1. Role of ATP-sensitive K+ channels in antinociception induced by R-PIA, an adenosine A1 receptor agonist.
    Ocaña M; Baeyens JM
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):57-62. PubMed ID: 7935855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subgroups among mu-opioid receptor agonists distinguished by ATP-sensitive K+ channel-acting drugs.
    Ocaña M; Del Pozo E; Barrios M; Baeyens JM
    Br J Pharmacol; 1995 Mar; 114(6):1296-302. PubMed ID: 7620721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of K+ channel blockers on antinociception induced by alpha 2-adrenoceptor, GABAB and kappa-opioid receptor agonists.
    Ocaña M; Baeyens JM
    Br J Pharmacol; 1993 Nov; 110(3):1049-54. PubMed ID: 7905339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channel blockade of atrial negative inotropic responses to P1-purinoceptor and muscarinic receptor agonists and to cromakalim.
    Urquhart RA; Ford WR; Broadley KJ
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):279-88. PubMed ID: 7679163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of a pharmacologic interaction between ATP-sensitive potassium channels and adenosine A1 receptors in ischemic rat hearts.
    Grover GJ; Baird AJ; Sleph PG
    Cardiovasc Res; 1996 Apr; 31(4):511-7. PubMed ID: 8689642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in ATP-sensitive potassium channel-mediated antinociception in diabetic mice.
    Kamei J; Kawashima N; Narita M; Suzuki T; Misawa M; Kasuya Y
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):318-21. PubMed ID: 7862839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adenosine agonist R-phenylisopropyl-adenosine on halothane anesthesia and antinociception in rats.
    Ma HC; Wang YF; Feng CS; Zhao H; Dohi S
    Acta Pharmacol Sin; 2005 Feb; 26(2):181-5. PubMed ID: 15663896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of K+ channel blockers and openers on antinociception induced by agonists of 5-HT1A receptors.
    Robles LI; Barrios M; Del Pozo E; Dordal A; Baeyens JM
    Eur J Pharmacol; 1996 Jan; 295(2-3):181-8. PubMed ID: 8720582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A1 but not A2a receptor agonist reduces hyperalgesia caused by a surgical incision in rats: a pertussis toxin-sensitive G protein-dependent process.
    Zahn PK; Straub H; Wenk M; Pogatzki-Zahn EM
    Anesthesiology; 2007 Nov; 107(5):797-806. PubMed ID: 18073555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
    Ocaña M; Barrios M; Baeyens JM
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1136-42. PubMed ID: 8786544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of ATP-sensitive K+ channels in various stress-induced analgesia (SIA) in mice.
    Nakao K; Takahashi M; Kaneto H
    Jpn J Pharmacol; 1996 Jul; 71(3):269-72. PubMed ID: 8854212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-sensitive potassium channels in smooth muscle cells from guinea pig urinary bladder.
    Bonev AD; Nelson MT
    Am J Physiol; 1993 May; 264(5 Pt 1):C1190-200. PubMed ID: 8498480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of central ATP-sensitive potassium channels produces the antinociception and spinal noradrenaline turnover-enhancing effect in mice.
    Narita M; Takamori K; Kawashima N; Funada M; Kamei J; Suzuki T; Misawa M; Nagase H
    Psychopharmacology (Berl); 1993; 113(1):11-4. PubMed ID: 7862815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-dependent K+ channel blockers antagonize morphine- but not U-504,88H-induced antinociception.
    Ocaña M; Del Pozo E; Baeyens JM
    Eur J Pharmacol; 1993 Jan; 230(2):203-7. PubMed ID: 8422902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium channel blockers differentially affect carbachol and (-)-N6-phenylisopropyladenosine on guinea-pig atria.
    De Biasi M; Froldi G; Ragazzi E; Pandolfo L; Caparrotta L; Fassina G
    Br J Pharmacol; 1989 Jul; 97(3):866-72. PubMed ID: 2547489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of K+ -channels in homotaurine-induced analgesia.
    Serrano MI; Serrano JS; Asadi I; Fernández A; Serrano-Martino MC
    Fundam Clin Pharmacol; 2001 Jun; 15(3):167-73. PubMed ID: 11468027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliquidone, an ATP-dependent K+ channel antagonist, antagonizes morphine-induced hypermotility.
    Ocaña M; Del Pozo E; Baeyens JM
    Eur J Pharmacol; 1993 Aug; 239(1-3):253-5. PubMed ID: 8223904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-sensitive K+ channels mediate regulation of substance P release via the prejunctional histamine H3 receptor.
    Ohkubo T; Shibata M
    Eur J Pharmacol; 1995 Apr; 277(1):45-9. PubMed ID: 7543412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.